Katti Jessen

发表论文 120 篇 · 总被引 3169 次 · h-index 18

代表论文

• Preclinical evaluation of the ROR1‐targeting antibody–drug conjugates zilovertamab vedotin and VLS‐211 against B‐cell ALL patient‐derived xenografts (2026 · HemaSphere)
• Targeting a novel surface antigen, ryk, with the antibody-drug conjugate, slv-404, is effective in richter transformation patient-derived xenografts (2025 · Blood)
• Abstract 6015: Unveiling RYK: A breakthrough tumor-associated antigen in lymphoma treatment (2025 · Cancer Research)
• Abstract LB187: Investigating the roles of ROR1/2 in non-small cell lung carcinoma NSCLC and potential therapeutic applications (2024 · Cancer Research)
• Abstract 1905: The ROR1 antibody-drug conjugate, MK-2140, enhances the efficacy of established drugs in preclinical models of pediatric acute lymphoblastic leukemia (2024 · Cancer Research)
• Data from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer (2023)